
Results
3
3 companies
Kuros Biosciences
Market Cap: CHF 848.4m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 21.50
7D
1.6%
1Y
-26.4%
MindMaze Therapeutics Holding
Market Cap: CHF 24.4m
Operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally.
MMTX
CHF 0.16
7D
-13.5%
1Y
n/a
Cosmo
Market Cap: CHF 1.0b
A life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally.
COPN
CHF 64.00
7D
-1.5%
1Y
2.7%